140 related articles for article (PubMed ID: 29220018)
1. Ablynx's nanobody fragments go places antibodies cannot.
Sheridan C
Nat Biotechnol; 2017 Dec; 35(12):1115-1117. PubMed ID: 29220018
[No Abstract] [Full Text] [Related]
2. Small nanobody drugs win big backing from pharma.
Williams SC
Nat Med; 2013 Nov; 19(11):1355-6. PubMed ID: 24202374
[No Abstract] [Full Text] [Related]
3. Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applications.
Wang Y; Fan Z; Shao L; Kong X; Hou X; Tian D; Sun Y; Xiao Y; Yu L
Int J Nanomedicine; 2016; 11():3287-303. PubMed ID: 27499623
[TBL] [Abstract][Full Text] [Related]
4. [Advances in the study of natural small molecular antibody].
Zhu L; Zhang DP
Yao Xue Xue Bao; 2012 Oct; 47(10):1281-6. PubMed ID: 23289139
[TBL] [Abstract][Full Text] [Related]
5. Camelid and shark single domain antibodies: structural features and therapeutic potential.
Könning D; Zielonka S; Grzeschik J; Empting M; Valldorf B; Krah S; Schröter C; Sellmann C; Hock B; Kolmar H
Curr Opin Struct Biol; 2017 Aug; 45():10-16. PubMed ID: 27865111
[TBL] [Abstract][Full Text] [Related]
6. [Progress in nanobody and its application in diagnosis].
Kong Q; Yao Y; Chen R; Lu S
Sheng Wu Gong Cheng Xue Bao; 2014 Sep; 30(9):1351-61. PubMed ID: 25720150
[TBL] [Abstract][Full Text] [Related]
7. Nanobodies and their potential applications.
Hassanzadeh-Ghassabeh G; Devoogdt N; De Pauw P; Vincke C; Muyldermans S
Nanomedicine (Lond); 2013 Jun; 8(6):1013-26. PubMed ID: 23730699
[TBL] [Abstract][Full Text] [Related]
8. Nanobody-based cancer therapy of solid tumors.
Kijanka M; Dorresteijn B; Oliveira S; van Bergen en Henegouwen PM
Nanomedicine (Lond); 2015 Jan; 10(1):161-74. PubMed ID: 25597775
[TBL] [Abstract][Full Text] [Related]
9. Kiran Mazumdar-Shaw.
Jayaraman KS
Nat Biotechnol; 2005 Jan; 23(1):11. PubMed ID: 15637602
[No Abstract] [Full Text] [Related]
10. (18)F-nanobody for PET imaging of HER2 overexpressing tumors.
Xavier C; Blykers A; Vaneycken I; D'Huyvetter M; Heemskerk J; Lahoutte T; Devoogdt N; Caveliers V
Nucl Med Biol; 2016 Apr; 43(4):247-52. PubMed ID: 27067045
[TBL] [Abstract][Full Text] [Related]
11. Nanobodies: natural single-domain antibodies.
Muyldermans S
Annu Rev Biochem; 2013; 82():775-97. PubMed ID: 23495938
[TBL] [Abstract][Full Text] [Related]
12. Development of a novel nano-sized anti-VEGFA nanobody with enhanced physicochemical and pharmacokinetic properties.
Khodabakhsh F; Norouzian D; Vaziri B; Ahangari Cohan R; Sardari S; Mahboudi F; Behdani M; Mansouri K; Mehdizadeh A
Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1402-1414. PubMed ID: 28841807
[TBL] [Abstract][Full Text] [Related]
13. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM
J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460
[TBL] [Abstract][Full Text] [Related]
14. Introduction to heavy chain antibodies and derived Nanobodies.
Vincke C; Muyldermans S
Methods Mol Biol; 2012; 911():15-26. PubMed ID: 22886243
[TBL] [Abstract][Full Text] [Related]
15. Tech transfer-slow progress.
Lawrence S
Nat Biotechnol; 2005 Jan; 23(1):12. PubMed ID: 15637603
[No Abstract] [Full Text] [Related]
16. Academic industry relationships in biotechnology: a primer on policy and practice.
Campbell EG; Blumenthal D
Cloning; 2000; 2(3):129-36. PubMed ID: 16218849
[TBL] [Abstract][Full Text] [Related]
17. Novel therapy based on camelid nanobodies.
Unciti-Broceta JD; Del Castillo T; Soriano M; Magez S; Garcia-Salcedo JA
Ther Deliv; 2013 Oct; 4(10):1321-36. PubMed ID: 24116915
[TBL] [Abstract][Full Text] [Related]
18. A nanobody directed to a functional epitope on VEGF, as a novel strategy for cancer treatment.
Farajpour Z; Rahbarizadeh F; Kazemi B; Ahmadvand D
Biochem Biophys Res Commun; 2014 Mar; 446(1):132-6. PubMed ID: 24569074
[TBL] [Abstract][Full Text] [Related]
19. Study critiques corporate control of trials.
Niiler E
Nat Biotechnol; 2002 Dec; 20(12):1180. PubMed ID: 12454659
[No Abstract] [Full Text] [Related]
20. How do you measure "success" in a biotechnology company?
Greetham EM
Nat Biotechnol; 1998 May; 16 Suppl():59-60. PubMed ID: 9591275
[No Abstract] [Full Text] [Related]
[Next] [New Search]
